School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
Department of Clinical Laboratory, Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
Microbiol Spectr. 2024 Oct 3;12(10):e0387423. doi: 10.1128/spectrum.03874-23. Epub 2024 Aug 20.
is a potential pathogen that has not been studied comprehensively. The emergence of multidrug-resistant (MDR) , specifically strains resistant to tigecycline and carbapenem, presents a significant challenge to clinical treatment. This investigation aimed to characterize MDR strain FK8966, co-carrying , , and by plasmids. It was observed that FK8966's MDR was primarily because of the IncHI1B-like plasmid co-carrying and , and an IncFIB(K)/IncFII(K) plasmid harboring . Furthermore, the phylogenetic analysis revealed that IncHI1B-like plasmids carrying were disseminated among different bacteria, specifically in China. Additionally, according to the comparative genomic analysis, the MDR regions indicated that the gene cluster was inserted into the gene, while was present in transposon Tn linked to the class 1 integron (). It was also observed that an ΔTn insertion with made a novel harboring IncFIB(K)/IncFII(K) plasmid. The antimicrobial resistance prevalence and phylogenetic analyses of strains indicated that FK8966 is a distinct MDR branch of . Furthermore, CRISPR-Cas system analysis showed that many CRISPR-Cas systems lacked spacers matching the two aforementioned novel resistance plasmids, suggesting that these resistance plasmids have the potential to disseminate within . Therefore, the spread of MDR and plasmids warrants further attention.IMPORTANCEThe emergence of multidrug-resistant poses a great threat to clinical care, and the situation is exacerbated by the dissemination of tigecycline- and carbapenem-resistant genes. Therefore, monitoring these pathogens and their resistance plasmids is urgent and crucial. This study identified tigecycline- and carbapenem-resistant strain, FK8966. Furthermore, it is the first study to report the coexistence of , , and in . Moreover, the CRISPR-Cas system of many lacks spacers that match the plasmids carried by FK8966, which are crucial for mediating resistance against tigecycline and carbapenems, indicating their potential to disseminate within .
是一种尚未被充分研究的潜在病原体。特别是对替加环素和碳青霉烯类药物耐药的多药耐药(MDR)菌株的出现,给临床治疗带来了巨大挑战。本研究旨在对携带质粒的 MDR 菌株 FK8966 进行表型特征鉴定,该质粒同时携带、和。研究发现 FK8966 的 MDR 主要是由于携带 IncHI1B 样质粒和,以及一个携带的 IncFIB(K)/IncFII(K)质粒。此外,系统发育分析显示,携带 IncHI1B 样质粒的在不同细菌之间传播,特别是在中国。此外,根据比较基因组分析,MDR 区域表明基因簇插入到基因中,而存在于与类 1 整合子()相连的转座子 Tn 中。还观察到 Tn 插入缺失导致一个新的携带 IncFIB(K)/IncFII(K)质粒的出现。菌株的抗菌药物耐药性流行情况和系统发育分析表明,FK8966 是一个独特的 MDR 分支。此外,CRISPR-Cas 系统分析表明,许多缺乏与上述两种新型耐药质粒匹配的间隔序列,这表明这些耐药质粒有可能在传播。因此,MDR 和质粒的传播值得进一步关注。
多药耐药的出现对临床治疗构成了巨大威胁,而替加环素和碳青霉烯类耐药基因的传播更是加剧了这一情况。因此,监测这些病原体及其耐药质粒是紧迫和至关重要的。本研究鉴定了替加环素和碳青霉烯类耐药的菌株 FK8966。此外,这是首次报道在同时存在、和。此外,许多的 CRISPR-Cas 系统缺乏与 FK8966 携带的质粒匹配的间隔序列,而这些质粒对于介导对替加环素和碳青霉烯类的耐药性至关重要,这表明它们有可能在传播。